Rahul Aras

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Eugene S. Chung, Leslie W. Miller, Amit N. Patel et al. · European Heart Journal · 2015 · 171 citations · Full text

Continuous Delivery of Stromal Cell-Derived Factor-1 from Alginate Scaffolds Accelerates Wound Healing

Sina Y. Rabbany, Joseph Pastore, Masaya Yamamoto et al. · Cell Transplantation · 2010 · 152 citations · Full text

Tissue Engineering, Engineering, Biomaterials Design +22

Extensive repetitive DNA facilitates prokaryotic genome plasticity

Rahul Aras, Josephine Kang, Ariane I Tschumi et al. · Proceedings of the National Academy of Sciences · 2003 · 132 citations · Full text

Comparative Genomics, Genetics, Genomic Mechanism +20

An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer et al. · Circulation Research · 2013 · 132 citations

Expression of the Multidrug Resistance Transporter NorA from <i>Staphylococcus aureus</i> Is Modified by a Two-Component Regulatory System

Bénédicte Fournier, Rahul Aras, David C. Hooper · Journal of Bacteriology · 2000 · 122 citations · Full text